BioCentury | Mar 24, 2008
Finance

Nomura's investments

...& Co.; Advent Venture Partners; CDC Ixis Innovation; CDIB BioScience Venture Management; Cogene Biotech Ventures; Easton Hunt Capital Partners...
BioCentury | May 16, 2005
Finance

Ebb & Flow

...million vehicle, about half of which would be earmarked for life sciences. Easton's current fund, Easton Hunt Capital Partners...
BioCentury | Apr 19, 2004
Emerging Company Profile

Corporate Profile

...Academy Venture Fund; Auriga Ventures; Bison Capital; CDC Innovation; CDIB BioScience Ventures; Cogene Biotech Ventures; Easton Hunt Capital Partners...
BioCentury | Apr 12, 2004
Company News

YM BioSciences board of directors update

...YM BioSciences Inc. (TSE:YM; LSE:YMBA), Mississauga, Ontario Business: Cancer Appointed: John Friedman, managing partner at Easton Hunt Capital Partners WIR...
BioCentury | Mar 29, 2004
Strategy

All that Jazz . . .

...JAFCO; Cogene Biotech Ventures; Bison Capital; Rock Castle Ventures; New Enterprise Associates; CDIB BioScience Ventures; Easton Hunt Capital Partners...
BioCentury | Aug 18, 2003
Company News

Renovis board of directors update

...Renovis Inc. , South San Francisco, Calif. Business: Neurology Appointed: John Friedman, managing partner of Easton Hunt Capital Partners WIR...
BioCentury | May 12, 2003
Finance

Ebb & Flow

...significant upcoming milestones, as Acorda raised $55.3 million in its third venture round led by Easton Hunt Capital Partners...
BioCentury | May 9, 2003
Top Story

Acorda raises $55.3M

...Acorda (Hawthorne, N.Y.) raised $55.3 million in a private round led by Easton Hunt Capital Partners. Other investors included...
BioCentury | Dec 17, 2002
Financial News

Transave raises $12 million

...specialist Transave (Monmouth Junction, N.J.) raised $12 million in a series B round led by Easton Hunt Capital Partners...
BioCentury | Dec 9, 2002
Finance

Ebb & Flow

...for neurodegenerative, neuropsychiatric and gastrointestinal diseases. Other investors included New Enterprise Associates; CDIB BioScience Ventures; Easton Hunt Capital Partners...
Items per page:
1 - 10 of 11
BioCentury | Mar 24, 2008
Finance

Nomura's investments

...& Co.; Advent Venture Partners; CDC Ixis Innovation; CDIB BioScience Venture Management; Cogene Biotech Ventures; Easton Hunt Capital Partners...
BioCentury | May 16, 2005
Finance

Ebb & Flow

...million vehicle, about half of which would be earmarked for life sciences. Easton's current fund, Easton Hunt Capital Partners...
BioCentury | Apr 19, 2004
Emerging Company Profile

Corporate Profile

...Academy Venture Fund; Auriga Ventures; Bison Capital; CDC Innovation; CDIB BioScience Ventures; Cogene Biotech Ventures; Easton Hunt Capital Partners...
BioCentury | Apr 12, 2004
Company News

YM BioSciences board of directors update

...YM BioSciences Inc. (TSE:YM; LSE:YMBA), Mississauga, Ontario Business: Cancer Appointed: John Friedman, managing partner at Easton Hunt Capital Partners WIR...
BioCentury | Mar 29, 2004
Strategy

All that Jazz . . .

...JAFCO; Cogene Biotech Ventures; Bison Capital; Rock Castle Ventures; New Enterprise Associates; CDIB BioScience Ventures; Easton Hunt Capital Partners...
BioCentury | Aug 18, 2003
Company News

Renovis board of directors update

...Renovis Inc. , South San Francisco, Calif. Business: Neurology Appointed: John Friedman, managing partner of Easton Hunt Capital Partners WIR...
BioCentury | May 12, 2003
Finance

Ebb & Flow

...significant upcoming milestones, as Acorda raised $55.3 million in its third venture round led by Easton Hunt Capital Partners...
BioCentury | May 9, 2003
Top Story

Acorda raises $55.3M

...Acorda (Hawthorne, N.Y.) raised $55.3 million in a private round led by Easton Hunt Capital Partners. Other investors included...
BioCentury | Dec 17, 2002
Financial News

Transave raises $12 million

...specialist Transave (Monmouth Junction, N.J.) raised $12 million in a series B round led by Easton Hunt Capital Partners...
BioCentury | Dec 9, 2002
Finance

Ebb & Flow

...for neurodegenerative, neuropsychiatric and gastrointestinal diseases. Other investors included New Enterprise Associates; CDIB BioScience Ventures; Easton Hunt Capital Partners...
Items per page:
1 - 10 of 11